Your session is about to expire
← Back to Search
Artificial Disc Replacement
PerQdisc® Nucleus Replacement Device. for Degenerative Disc Disease
N/A
Waitlist Available
Research Sponsored by Spinal Stabilization Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Study Summary
This trial will test a new device to treat chronic low back pain. The device is placed minimally invasively and safety data will be collected.
Eligible Conditions
- Chronic Lower Back Pain
- Degenerative Disc Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement in back pain as measured by 10-centimeter Visual Analog Scale (VAS)
Improvement in degree of disability as measured by the Oswestry Disability Index (ODI)
MRI assessment of the endplate Modic changes.
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Nucleus ReplacementExperimental Treatment1 Intervention
All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.
Find a Location
Who is running the clinical trial?
Spinal Stabilization TechnologiesLead Sponsor
4 Previous Clinical Trials
203 Total Patients Enrolled
Michael Hess, MDStudy ChairLondon Spine Clinic/ATOS-Klinik
3 Previous Clinical Trials
153 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Montreal General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger